sars cov 2 antigen testing program covid atp a protocol for a longitudinal study in 14 uk cancer centers
Penny Kechagioglou, S Léwi, Catherine F. Hatton(Newcastle University), Amy J. Schuh, B Lubowa, JA Gonzalez Ferreira, Jitendra Parmar, Jennifer L. Crombie(Dana-Farber Cancer Institute), Kavitha Ramasamy, Elena Moreno-Olmedo, Eduardo Bohórquez López, David Fernández Rivas(University of Twente)
Infectious Diseases Diagnosis & Treatment
January 1, 2020
Cited by 0
Related Papers
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
|Blood|2019|187
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy
|Blood|2024|132
The treatment of Burkitt lymphoma in adults
|Blood|2020|105
Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
|Frontiers in Oncology|2019|104